OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating reaffirmed by equities research analysts at FinnCap in a report issued on Wednesday.

Shares of OptiBiotix Health PLC (OPTI) opened at 73.40 on Wednesday. The stock’s 50 day moving average is GBX 69.48 and its 200 day moving average is GBX 68.89. The stock’s market cap is GBX 57.65 million. OptiBiotix Health PLC has a 52-week low of GBX 59.00 and a 52-week high of GBX 90.00.

ILLEGAL ACTIVITY WARNING: “OptiBiotix Health PLC’s (OPTI) Corporate Rating Reaffirmed at FinnCap” was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/11/01/optibiotix-health-plcs-opti-corporate-rating-reaffirmed-at-finncap.html.

About OptiBiotix Health PLC

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related companies with MarketBeat.com's FREE daily email newsletter.